Literature DB >> 19853012

A dual-hit animal model for age-related parkinsonism.

Heather A Boger1, Ann-Charlotte Granholm, Jacqueline F McGinty, Lawrence D Middaugh.   

Abstract

Parkinson's disease is a neurological disorder which afflicts an increasing number of individuals. If the wider complex of extrapyramidal symptoms referred to as "age-related parkinsonism" is included, the incidence is near 50% of the population above 80 years of age. This review summarizes recent studies from our laboratories as well as other research groups in the quest to explore the multi-faceted etiology of age-related neurodegeneration, in general, and degeneration of the substantia nigra dopaminergic neurons, in particular. Our work during recent years has focused on assessment of potential interactive effects of a reduction in glial cell line-derived neurotrophic factor (GDNF) and the aging process (intrinsic factors) and early neurotoxin exposure (an extrinsic factor) on dopamine (DA) systems and the behaviors they mediate. The guiding hypothesis directing the research to be described was that a combination of the two factors would exacerbate the decline in the DA transmitter system function that occurs during aging. The results obtained were consistent with the well-established aging-related decline in function and structure of neurons utilizing DA as a transmitter and motor function, and extended knowledge by establishing that the genetic reduction of Gdnf exacerbated these aging related changes. Thus, GDNF reduction appears to increase the vulnerability of the DA neurons to the many different challenges associated with the aging process. Assessment of methamphetamine effects on young Gdnf(+/-) mice indicated that reduced GDNF availability increased the vulnerability of DA systems to this well-established neurotoxin. The work discussed in this review is consistent with earlier work demonstrating the importance of GDNF for maintenance of DA neurons and also provides a novel model for progressive DA degeneration and motor dysfunction. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853012      PMCID: PMC3991553          DOI: 10.1016/j.pneurobio.2009.10.013

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  137 in total

1.  Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats.

Authors:  Wayne A Cass; Michael E Harned; Sherry L Bailey
Journal:  Brain Res       Date:  2002-05-31       Impact factor: 3.252

2.  Cell death of dopamine neurons in aging and Parkinson's disease.

Authors:  M Naoi; W Maruyama
Journal:  Mech Ageing Dev       Date:  1999-11       Impact factor: 5.432

Review 3.  The nerve growth factor and the neuroscience chess board.

Authors:  R Levi-Montalcini
Journal:  Arch Ital Biol       Date:  2003-03       Impact factor: 1.000

4.  3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

Review 5.  Progress in Parkinson's disease-where do we stand?

Authors:  André Toulouse; Aideen M Sullivan
Journal:  Prog Neurobiol       Date:  2008-06-05       Impact factor: 11.685

6.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

7.  Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice.

Authors:  Luise A Cullen-McEwen; Michelle M Kett; John Dowling; Warwick P Anderson; John F Bertram
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

8.  Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.

Authors:  Chun-Hung Lin; Jui-Yen Huang; Cheng-Hsin Ching; Jih-Ing Chuang
Journal:  J Pineal Res       Date:  2008-03       Impact factor: 13.007

9.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

10.  Aging and motor learning: a possible role for norepinephrine in cerebellar plasticity.

Authors:  P Bickford
Journal:  Rev Neurosci       Date:  1995 Jan-Mar       Impact factor: 4.353

View more
  19 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

2.  Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.

Authors:  Amanda M Gleixner; Jessica M Posimo; Deepti B Pant; Matthew P Henderson; Rehana K Leak
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

3.  Three-dimensional rodent motion analysis and neurodegenerative disorders.

Authors:  Tasos Karakostas; Simon Hsiang; Heather Boger; Lawrence Middaugh; Ann-Charlotte Granholm
Journal:  J Neurosci Methods       Date:  2013-10-12       Impact factor: 2.390

Review 4.  Parkinson's disease: what the model systems have taught us so far.

Authors:  Swagata Ghatak; Dorit Trudler; Nima Dolatabadi; Rajesh Ambasudhan
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 5.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

6.  Adaptation and sensitization to proteotoxic stress.

Authors:  Rehana K Leak
Journal:  Dose Response       Date:  2013-08-05       Impact factor: 2.658

7.  Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  F L'Episcopo; C Tirolo; N Testa; S Caniglia; M C Morale; C Cossetti; P D'Adamo; E Zardini; L Andreoni; A E C Ihekwaba; P A Serra; D Franciotta; G Martino; S Pluchino; B Marchetti
Journal:  Neurobiol Dis       Date:  2010-11-05       Impact factor: 5.996

8.  Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.

Authors:  B A Morrow; R H Roth; D E Redmond; J D Elsworth
Journal:  Neuroscience       Date:  2011-06-01       Impact factor: 3.590

Review 9.  Parkinson's disease, aging and adult neurogenesis: Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair.

Authors:  Bianca Marchetti; Cataldo Tirolo; Francesca L'Episcopo; Salvatore Caniglia; Nunzio Testa; Jayden A Smith; Stefano Pluchino; Maria F Serapide
Journal:  Aging Cell       Date:  2020-02-12       Impact factor: 9.304

10.  Synergistic stress exacerbation in hippocampal neurons: Evidence favoring the dual-hit hypothesis of neurodegeneration.

Authors:  Scott D Heinemann; Jessica M Posimo; Daniel M Mason; Daniel F Hutchison; Rehana K Leak
Journal:  Hippocampus       Date:  2016-03-29       Impact factor: 3.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.